Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Headache | Case report

Dexamfetamine

Rebound effect in the form of headaches following off-label therapy (in unapproved indication) with dexamfetamine

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Check JH. Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome - A case that emphasizes the role of the gynecologist in treating headaches in women. Clinical and Experimental Obstetrics and Gynecology 43: 119-122, No. 1, Feb 2016. Available from: URL: https://dx.doi.org/10.12891/ceog2105.2016 Check JH. Dextroamphetamine sulfate treatment eradicates long-term chronic severe headaches from temporomandibular joint syndrome - A case that emphasizes the role of the gynecologist in treating headaches in women. Clinical and Experimental Obstetrics and Gynecology 43: 119-122, No. 1, Feb 2016. Available from: URL: https://​dx.​doi.​org/​10.​12891/​ceog2105.​2016
Metadata
Title
Dexamfetamine
Rebound effect in the form of headaches following off-label therapy (in unapproved indication) with dexamfetamine
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56810-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Baricitinib

Case report

Empagliflozin